Last updated: 2025-12-23 22:01:14 ET
Households that start taking blockbuster GLP-1 appetite suppressants like Ozempic and Wegovy slash food spending within months, according to a study.
The FDA on Monday approved the first-ever GLP-1 pill from the Danish pharmaceutical giant.
A cheaper, easier-to-use version of Wegovy is coming to the US soon
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.
U.S. regulators have approved a pill version of the weight-loss drug Wegovy
It marks a first in this new era of weight-loss medications with Wegovy being the only so far to gain approval for a pill version of their shot.
Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for obesity.
